Effect of a monoclonal antibody against human relaxin-2 on cancer cell growth inhibition

被引：3
|
作者：
Park, Byoung Kwon [1 ,2 ]
Lee, Su In [2 ]
Lee, Younghee [3 ]
Cho, Sooyoung [4 ]
Lee, Young Seek [5 ]
Kwon, Hyung-Joo [1 ,2 ]
机构：
[1] Hallym Univ, Coll Med, Ctr Med Sci Res, Chunchon 24252, South Korea
[2] Hallym Univ, Coll Med, Dept Microbiol, Chunchon 24252, South Korea
[3] Chungbuk Natl Univ, Dept Biochem, Coll Nat Sci, Cheongju 28644, South Korea
[4] Seoul Natl Univ, Res Inst Vet Sci BK21, Lab Dev Biol & Genom, Coll Vet Med,Program Vet Sci, Seoul 08826, South Korea
[5] Hanyang Univ, Div Mol & Life Sci, Coll Sci & Technol, Ansan 15588, South Korea
来源：
APPLIED BIOLOGICAL CHEMISTRY | 2016年 / 59卷 / 05期
基金：
新加坡国家研究基金会;
关键词：
Cancer; Monoclonal antibody; Relaxin-2; DNA-LIPOSOME COMPLEX; XENOGRAFT TUMOR-GROWTH; CPG-DNA; INCREASES SECRETION; CERVICAL GROWTH; IN-VIVO; PROGRESSION; EXPRESSION; PIG; OSTEOSARCOMA;
D O I：
10.1007/s13765-016-0221-4
中图分类号：
TS2 [食品工业];
学科分类号：
0832 ;
摘要：
Relaxin-2 has gained much attention because of its importance in cancer cell proliferation, invasion, and angiogenesis. However, the potential of relaxin-2 as a target for immunotherapy has never been directly validated before. In the present study, we produced a human relaxin-2-specific antibody by immunizing mice using a specific liposome complex containing relaxin-2 epitope peptide and CpG-DNA. We isolated a hybridoma clone, 1B11F12, producing the anti-relaxin-2 monoclonal antibody. We confirmed with immunoprecipitation analysis that the antibody specifically recognizes native human relaxin-2. Treatment with the antibody suppressed the growth of some cancer cell lines. Therefore, we suggest that relaxin-2 could be a reasonable target of cancer therapeutics, and the monoclonal antibody could be used to treat cancer in humans.
引用
收藏
页码：739 / 746
页数：8
相关论文
共 50 条
  • [31] Inhibition of cancer cell growth by anti-Tn monoclonal antibody MLS128
    Morita, Noriyuki
    Yajima, Yukiko
    Asanuma, Hideki
    Nakada, Hiroshi
    Fujita-Yamaguchi, Yoko
    BIOSCIENCE TRENDS, 2009, 3 (01) : 32 - 37
  • [32] GROWTH MODULATION OF HUMAN CANCER CELL-LINES BY FREE MONOCLONAL-ANTIBODY AND A DRUG-MONOCLONAL ANTIBODY CONJUGATE
    GAREWAL, H
    SLOAN, D
    AHMANN, F
    RAMSAY, L
    DESHMUKH, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 419 - 419
  • [33] Plasma levels of relaxin-2 correlate with severity of human congestive heart failure
    Dschietzig, T
    Richter, C
    Lauie, M
    Stangl, K
    EUROPEAN HEART JOURNAL, 2000, 21 : 404 - 404
  • [34] Administration study of recombinant human relaxin-2 in horse for doping control purpose
    Kwok, Wai Him
    Choi, Timmy L. S.
    Leung, Gary N. W.
    Wong, April S. Y.
    Yue, Samuel K.
    Wan, Terence S. M.
    Ho, Emmie N. M.
    DRUG TESTING AND ANALYSIS, 2020, 12 (03) : 361 - 370
  • [35] Plasma levels and myocardial expression of relaxin-2 are increased in human heart failure
    Dschietzig, T
    Richter, C
    Bartsch, C
    Laule, M
    Stangl, K
    CIRCULATION, 2000, 102 (18) : 594 - 594
  • [36] Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against VEGFR-2
    Kunkel, P
    Ulbricht, U
    Bohlen, P
    Brockmann, M
    Stavrou, D
    Westphal, M
    Lamszus, K
    ACTA NEUROPATHOLOGICA, 2001, 102 (05) : 532 - 532
  • [37] GROWTH-INHIBITION OF XENOTRANSPLANTED HUMAN CARCINOMAS BY A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE EPIDERMAL GROWTH-FACTOR RECEPTOR
    SCHNURCH, HG
    STEGMULLER, M
    VERING, A
    BECKMANN, MW
    BENDER, HG
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (04) : 491 - 496
  • [38] Inhibition of the in vitro growth of human gastric cancer cells by a monoclonal anti-bombesin antibody.
    Gokhale, JA
    Preston, SR
    Farmery, SM
    Primrose, JN
    GASTROENTEROLOGY, 1996, 110 (04) : A1074 - A1074
  • [39] Development of a monoclonal antibody against human epidermal growth factor receptor 2 (HER2)
    Takei, Junko
    Kaneko, Mika
    Ohishi, Tomokazu
    Sayama, Yusuke
    Kawada, Manabu
    Harada, Hiroyuki
    Kato, Yukinari
    CANCER SCIENCE, 2021, 112 : 545 - 545
  • [40] INHIBITION OF PLATELET-AGGREGATION BY A MONOCLONAL-ANTIBODY AGAINST HUMAN FIBRONECTIN
    DIXIT, VM
    HAVERSTICK, DM
    OROURKE, K
    HENNESSY, SW
    BROEKELMANN, TJ
    MCDONALD, JA
    GRANT, GA
    SANTORO, SA
    FRAZIER, WA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (11) : 3844 - 3848
12345